Crizotinib as a personalized alternative for targeted anaplastic lymphoma kinase rearrangement in previously treated patients with non-small-cell lung cancer

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Anaplastic Lymphoma Kinase Rearrangement ◽

Previously Treated Patients ◽

Cost-Effectiveness Of Ceritinib In Previously Treated Patients With Crizotinib In Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small Cell Lung Cancer In Canada

Value in Health ◽

10.1016/j.jval.2015.09.1199 ◽

2015 ◽

Vol 18 (7) ◽

pp. A462 ◽

Cited By ~ 1

Author(s):

Z Zhou ◽

M Hurry ◽

J Zhang ◽

L Fan ◽

C Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Previously Treated Patients ◽

Diagnostic and therapeutic issues for patients with advanced non-small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (Review)

International Journal of Oncology ◽

10.3892/ijo.2014.2453 ◽

2014 ◽

Vol 45 (2) ◽

pp. 509-515 ◽

Cited By ~ 8

Author(s):

MASSIMO DI MAIO ◽

FILIPPO DE MARINIS ◽

FRED R. HIRSCH ◽

CESARE GRIDELLI

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Crizotinib: a guide to its use in previously treated advanced anaplastic lymphoma kinase-positive non-small cell lung cancer in the EU

Drugs & Therapy Perspectives ◽

10.1007/s40267-013-0015-2 ◽

2013 ◽

Vol 29 (3) ◽

pp. 64-68

Author(s):

Mary Hines ◽

Katherine A. Lyseng-Williamson ◽

Monique P. Curran

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Previously Treated ◽

The Eu

Ceritinib vs chemotherapy (CT) in patients (pts) with advanced anaplastic lymphoma kinase (ALK)-rearranged (ALK+) non-small cell lung cancer (NSCLC) previously treated with CT and crizotinib (CRZ): Results from the confirmatory phase 3 ASCEND-5 study

Annals of Oncology ◽

10.1093/annonc/mdw435.41 ◽

2016 ◽

Vol 27 ◽

pp. vi579 ◽

Cited By ~ 10

Author(s):

G. Scagliotti ◽

T.M. Kim ◽

L. Crinò ◽

G. Liu ◽

C. Gridelli ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Phase 3 ◽

Anaplastic Lymphoma ◽

Previously Treated ◽

Confirmatory Phase

Lorlatinib in previously treated anaplastic lymphoma kinase‐rearranged non–small cell lung cancer: Japanese subgroup analysis of a global study

Cancer Science ◽

10.1111/cas.14576 ◽

2020 ◽

Vol 111 (10) ◽

pp. 3726-3738

Author(s):

Takashi Seto ◽

Hidetoshi Hayashi ◽

Miyako Satouchi ◽

Yasushi Goto ◽

Seiji Niho ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Subgroup Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Global Study ◽

Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancer

British Journal of Healthcare Management ◽

10.12968/bjhc.2016.22.10.486 ◽

2016 ◽

Vol 22 (10) ◽

pp. 486-487

Author(s):

Samreen Ahmed

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

CT Characteristics of Non–Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangement: A Systematic Review and Meta-Analysis

American Journal of Roentgenology ◽

10.2214/ajr.19.21485 ◽

2019 ◽

Vol 213 (5) ◽

pp. 1059-1072 ◽

Cited By ~ 1

Author(s):

Tae-Hyung Kim ◽

Sungmin Woo ◽

Soon Ho Yoon ◽

Darragh F. Halpenny ◽

Sangwon Han ◽

...

Keyword(s):

Lung Cancer ◽

Systematic Review ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Meta Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Cost-effectiveness of ceritinib in patients previously treated with crizotinib in anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer in Canada

Journal of Medical Economics ◽

10.1080/13696998.2016.1187151 ◽

2016 ◽

Vol 19 (10) ◽

pp. 936-944 ◽

Cited By ~ 8

Author(s):

Manjusha Hurry ◽

Zheng-Yi Zhou ◽

Jie Zhang ◽

Chenxue Zhang ◽

Liangyi Fan ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Prevalence and Clinical Impact of Concomitant Mutations in Anaplastic Lymphoma Kinase Rearrangement Advanced Non-small-Cell Lung Cancer (Guangdong Association of Thoracic Oncology Study 1055)

Frontiers in Oncology ◽

10.3389/fonc.2020.01216 ◽

2020 ◽

Vol 10 ◽

Author(s):

Meichen Li ◽

Xue Hou ◽

Chengzhi Zhou ◽

Weineng Feng ◽

Guanming Jiang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Clinical Impact ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Severe acute interstitial lung disease in a patient with anaplastic lymphoma kinase rearrangement–positive non–small cell lung cancer treated with alectinib

Investigational New Drugs ◽

10.1007/s10637-015-0284-9 ◽

2015 ◽

Vol 33 (5) ◽

pp. 1148-1150 ◽

Cited By ~ 9

Author(s):

Yuzo Yamamoto ◽

Isamu Okamoto ◽

Kohei Otsubo ◽

Eiji Iwama ◽

Naoki Hamada ◽

...

Keyword(s):

Lung Cancer ◽

Interstitial Lung Disease ◽

Small Cell Lung Cancer ◽

Lung Disease ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽